Net Cash Provided by (Used in) Investing Activities |
-17.7M |
USD |
|
Q3 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
250M |
shares |
+150% |
Q1 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
10.3M |
shares |
+3991% |
Q1 2022 |
Q3 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
886K |
USD |
|
Q3 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
258K |
USD |
+185% |
Q1 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
1.8M |
USD |
|
Q1 2023 |
Q3 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.8M |
USD |
|
Q1 2023 |
Q3 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q1 2023 |
Q3 2023 |
Additional Paid in Capital |
28.8M |
USD |
+746% |
Q1 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2023 |
Q3 2023 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Q3 2022 |
Q1 2022 |
Operating Leases, Future Minimum Payments, Due in Two Years |
44K |
USD |
|
Q1 2023 |
Q3 2023 |
Depreciation, Depletion and Amortization |
585K |
USD |
|
Q3 2022 |
Q1 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
-100% |
Q1 2023 |
Q3 2023 |
Operating Leases, Future Minimum Payments Due |
48.9K |
USD |
|
Q1 2023 |
Q3 2023 |
Interest Expense |
115K |
USD |
+2085% |
Q3 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2023 |
Q3 2023 |